Columbus, OH / New York, NY — Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally. The book’s ten macro trends span all spheres of healthcare, reflecting reinvented dynamics among providers, patients, payers—and some new players. 

In 2019 Health Trend Ten, each trend is accompanied by specific, elaborated examples, replete with over 100 infographics and images as well as focused exercises to drive home key takeaways. 

Underlying all trends in the report is the renewed, vital drive to understand patients—the unique journeys and needs of every population—through bigger, better, and more real-world data. Life sciences leaders are obtaining and using this data in novel ways: to accelerate trials; re-evaluate product launch; alleviate patient and doctor burdens; re-assess pricing models; hire some unexpected talent; and a host of other telling endeavors. 

Q3 of this year displayed many of pharma’s biggest players in full-throttle pursuit of many of these novel practices.

For instance, Novartis signed a deal with Shyft Analytics, a subsidiary of Medidata, to use two new life sciences platforms—Strata and Lumen Insights—to help commercialize therapies in some new populations throughout Europe. Strata manages Novartis’ burgeoning number of external commercial data sources, while Lumen Insights performs more downstream services to inform commercial teams about best practices. 

Additionally, Novartis recently presented new discoveries about the etiology of migraines, which were based on users’ input to the new app Migraine Buddy. 

Johnson & Johnson also made some major moves on the at-home data collection front, funding a study of the potential of wearable biosensors together with AI to detect adverse events in cancer treatment earlier than ever before. This new effort incorporates technologies from digital health startups VitalConnect and physIQ. 

Merck is pursuing new digital health technologies that facilitate chronic disease management. Its first effort focuses on diabetes, and a new platform, Map4health, offers not just peer and professional support via video and text messaging, but allows patients to track over time the data they provide, which has been shown to increase patient engagement—and enjoyment. 

Why This Matters

Often characterized as being behind the broader commercial world, healthcare is more than catching up. Leaders are blazing ahead with radical re-orgs and mega-investments in leading-edge tech, introducing new therapies faster and re-shaping the industry’s landscape as we know it. Stay current with Syneos Health’s 2019 Health Trend Ten

About the Author:

Ben helps spark innovative healthcare thinking as Associate Director of Innovation. Previously on the editorial staff of Vanity Fair, he brings experience in engaging, rigorous storytelling to the healthcare world. Ben’s goals are to move brands to rethink their roles, own their evolving narratives, and maintain vital and vigorous consumer relationships.